Details of the Drug Combination

General Information of Drug Combination (ID: DCYOG2K)

Drug Combination Name

Ethinyl Estradiol Brincidofovir

Indication

Disease Entry	Status	REF
Chronic myelogenous leukemia	Investigative	[1]

Component Drugs

Ethinyl Estradiol DMODJ40

Brincidofovir DMS0PND

Small molecular drug

2D MOL

3D MOL

3D MOL is unavailable

High-throughput Screening Result

Testing Cell Line: KBM-7

Zero Interaction Potency (ZIP) Score: 4.13

Bliss Independence Score: 4.13

Loewe Additivity Score: 4.75

LHighest Single Agent (HSA) Score: 4.75

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)

Indication(s) of Ethinyl Estradiol

Disease Entry	ICD 11	Status	REF
Acne vulgaris	ED80	Approved	[2]
Female hypogonadism	GA30.6	Approved	[3]
Hot flushes	GA30	Approved	[2]
Obsolete atrophic vulva	N.A.	Approved	[2]

Ethinyl Estradiol Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Estrogen receptor (ESR)	TTZAYWL	ESR1_HUMAN	Agonist	[9]
------------------------------------------------------------------------------------

Ethinyl Estradiol Interacts with 1 DTP Molecule(s)

DTP Name	DTP ID	UniProt ID	Mode of Action	REF
P-glycoprotein 1 (ABCB1)	DTUGYRD	MDR1_HUMAN	Substrate	[10]
------------------------------------------------------------------------------------

Ethinyl Estradiol Interacts with 6 DME Molecule(s)

DME Name	DME ID	UniProt ID	Mode of Action	REF
Cytochrome P450 3A4 (CYP3A4)	DE4LYSA	CP3A4_HUMAN	Metabolism	[11]
UDP-glucuronosyltransferase 1A1 (UGT1A1)	DEYGVN4	UD11_HUMAN	Metabolism	[12]
Cytochrome P450 1A1 (CYP1A1)	DE6OQ3W	CP1A1_HUMAN	Metabolism	[13]
Cytochrome P450 2C8 (CYP2C8)	DES5XRU	CP2C8_HUMAN	Metabolism	[14]
Cytochrome P450 2C9 (CYP2C9)	DE5IED8	CP2C9_HUMAN	Metabolism	[13]
Mephenytoin 4-hydroxylase (CYP2C19)	DEGTFWK	CP2CJ_HUMAN	Metabolism	[15]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 DME(s)

Ethinyl Estradiol Interacts with 280 DOT Molecule(s)

DOT Name	DOT ID	UniProt ID	Mode of Action	REF
Cytochrome P450 2C8 (CYP2C8)	OTHCWT42	CP2C8_HUMAN	Decreases Activity	[14]
Cytochrome P450 1A1 (CYP1A1)	OTE4EFH8	CP1A1_HUMAN	Decreases Expression	[16]
Cytochrome P450 3A4 (CYP3A4)	OTQGYY83	CP3A4_HUMAN	Increases Hydroxylation	[13]
Cytochrome P450 2C9 (CYP2C9)	OTGLBN29	CP2C9_HUMAN	Increases Hydroxylation	[13]
Cytochrome P450 2C19 (CYP2C19)	OTFMJYYE	CP2CJ_HUMAN	Increases Hydroxylation	[13]
ATP-dependent translocase ABCB1 (ABCB1)	OTEJROBO	MDR1_HUMAN	Increases Expression	[10]
Sulfotransferase 1E1 (SULT1E1)	OTGPJ517	ST1E1_HUMAN	Decreases Activity	[17]
Gamma-aminobutyric acid receptor subunit pi (GABRP)	OTGKA8WS	GBRP_HUMAN	Decreases Expression	[6]
Ectoderm-neural cortex protein 1 (ENC1)	OTJEUB6U	ENC1_HUMAN	Decreases Expression	[6]
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF1)	OTFK8KDP	NHRF1_HUMAN	Increases Expression	[6]
Neuropilin-1 (NRP1)	OTCGULYV	NRP1_HUMAN	Increases Expression	[6]
Transmembrane protease serine 2 (TMPRSS2)	OTN44YQ5	TMPS2_HUMAN	Decreases Expression	[6]
Insulin-induced gene 1 protein (INSIG1)	OTZF5X1D	INSI1_HUMAN	Increases Expression	[6]
Krueppel-like factor 4 (KLF4)	OT4O9RQW	KLF4_HUMAN	Increases Expression	[6]
Band 4.1-like protein 2 (EPB41L2)	OT6UABPM	E41L2_HUMAN	Increases Expression	[6]
Tetraspanin-1 (TSPAN1)	OTZQPIYK	TSN1_HUMAN	Decreases Expression	[6]
Microfibrillar-associated protein 3-like (MFAP3L)	OTNMHSAH	MFA3L_HUMAN	Increases Expression	[6]
Short-chain dehydrogenase/reductase 3 (DHRS3)	OTSK1DTP	DHRS3_HUMAN	Increases Expression	[6]
Dysferlin (DYSF)	OTNSKJU0	DYSF_HUMAN	Decreases Expression	[6]
Gamma-butyrobetaine dioxygenase (BBOX1)	OTKEX4RK	BODG_HUMAN	Decreases Expression	[6]
Nebulette (NEBL)	OT2WH1NC	NEBL_HUMAN	Decreases Expression	[6]
ATP-dependent DNA helicase Q5 (RECQL5)	OTVZMP1Q	RECQ5_HUMAN	Decreases Expression	[6]
Sorbin and SH3 domain-containing protein 2 (SORBS2)	OTJSX44Y	SRBS2_HUMAN	Decreases Expression	[6]
Serine protease 23 (PRSS23)	OT6DQAM1	PRS23_HUMAN	Decreases Expression	[6]
NADH dehydrogenase 1 beta subcomplex subunit 6 (NDUFB6)	OTIXNT91	NDUB6_HUMAN	Increases Expression	[6]
Rap guanine nucleotide exchange factor 3 (RAPGEF3)	OTMOW4Z4	RPGF3_HUMAN	Decreases Expression	[6]
Secretoglobin family 1D member 2 (SCGB1D2)	OTSYWZAQ	SG1D2_HUMAN	Increases Expression	[6]
Aldehyde dehydrogenase 1A1 (ALDH1A1)	OTCUWZKB	AL1A1_HUMAN	Decreases Expression	[6]
Carbonic anhydrase 2 (CA2)	OTJRMUAG	CAH2_HUMAN	Increases Expression	[6]
Protein c-Fos (FOS)	OTJBUVWS	FOS_HUMAN	Increases Expression	[6]
Myc proto-oncogene protein (MYC)	OTPV5LUK	MYC_HUMAN	Increases Expression	[6]
Protransforming growth factor alpha (TGFA)	OTPD1LL9	TGFA_HUMAN	Increases Expression	[6]
N-myc proto-oncogene protein (MYCN)	OTWD33K1	MYCN_HUMAN	Decreases Expression	[6]
Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCA)	OTWJTCRK	PCCA_HUMAN	Increases Expression	[6]
Alkaline phosphatase, placental type (ALPP)	OTZU4G9W	PPB1_HUMAN	Increases Expression	[6]
Collagen alpha-2(V) chain (COL5A2)	OT5VOSQE	CO5A2_HUMAN	Decreases Expression	[6]
Progesterone receptor (PGR)	OT0FZ3QE	PRGR_HUMAN	Increases Expression	[6]
Thrombospondin-1 (THBS1)	OT0ECWK3	TSP1_HUMAN	Increases Expression	[6]
Amino acid transporter heavy chain SLC3A2 (SLC3A2)	OTBR33M9	4F2_HUMAN	Increases Expression	[6]
Interleukin-6 receptor subunit alpha (IL6R)	OTCQL07Z	IL6RA_HUMAN	Increases Expression	[6]
Matrilysin (MMP7)	OTVT3SEJ	MMP7_HUMAN	Increases Expression	[6]
Stromelysin-2 (MMP10)	OTJDWW8Q	MMP10_HUMAN	Decreases Expression	[6]
Retinol-binding protein 1 (RBP1)	OTRP1MFC	RET1_HUMAN	Decreases Expression	[6]
Tropomyosin alpha-1 chain (TPM1)	OTD73X6R	TPM1_HUMAN	Decreases Expression	[6]
Interferon alpha-inducible protein 6 (IFI6)	OTWOOAM4	IFI6_HUMAN	Decreases Expression	[6]
Alkaline phosphatase, germ cell type (ALPG)	OTCIM29R	PPBN_HUMAN	Increases Expression	[6]
Creatine kinase B-type (CKB)	OTUCKOTT	KCRB_HUMAN	Increases Expression	[6]
Insulin-like growth factor-binding protein 3 (IGFBP3)	OTIX63TX	IBP3_HUMAN	Decreases Expression	[6]
Early growth response protein 1 (EGR1)	OTCP6XGZ	EGR1_HUMAN	Increases Expression	[6]
Endothelin-2 (EDN2)	OTQ7RCPI	EDN2_HUMAN	Decreases Expression	[6]
Collagen alpha-1(V) chain (COL5A1)	OT24078H	CO5A1_HUMAN	Increases Expression	[6]
Fibroblast growth factor receptor 2 (FGFR2)	OTLOPACK	FGFR2_HUMAN	Decreases Expression	[6]
Galanin peptides (GAL)	OTB3VPTO	GALA_HUMAN	Increases Expression	[6]
Fibroblast growth factor receptor 3 (FGFR3)	OTSAXDIL	FGFR3_HUMAN	Decreases Expression	[6]
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)	OT6RMDCE	KAPCB_HUMAN	Affects Expression	[6]
Prostaglandin G/H synthase 1 (PTGS1)	OTHCRLEC	PGH1_HUMAN	Decreases Expression	[6]
Insulin-like growth factor-binding protein 5 (IGFBP5)	OTRE5V0C	IBP5_HUMAN	Decreases Expression	[6]
CCN family member 2 (CCN2)	OTC39NSU	CCN2_HUMAN	Decreases Expression	[6]
Transcription factor HIVEP2 (HIVEP2)	OTVOMCW4	ZEP2_HUMAN	Decreases Expression	[6]
Sodium- and chloride-dependent taurine transporter (SLC6A6)	OT67U7G3	SC6A6_HUMAN	Decreases Expression	[6]
Prostaglandin G/H synthase 2 (PTGS2)	OT75U9M4	PGH2_HUMAN	Increases Expression	[6]
Activin receptor type-1B (ACVR1B)	OT778HIQ	ACV1B_HUMAN	Decreases Expression	[6]
Collagen alpha-1(XV) chain (COL15A1)	OTTFKK18	COFA1_HUMAN	Increases Expression	[6]
Replication factor C subunit 3 (RFC3)	OT1MS7AO	RFC3_HUMAN	Increases Expression	[6]
Exosome RNA helicase MTR4 (MTREX)	OTSQY30V	MTREX_HUMAN	Increases Expression	[6]
G protein-activated inward rectifier potassium channel 1 (KCNJ3)	OTHQG16J	KCNJ3_HUMAN	Decreases Expression	[6]
Retinol-binding protein 2 (RBP2)	OTR8QG5V	RET2_HUMAN	Decreases Expression	[6]
LIM domain kinase 2 (LIMK2)	OTRJD7VZ	LIMK2_HUMAN	Decreases Expression	[6]
ADP-ribosylation factor 3 (ARF3)	OTYYQX85	ARF3_HUMAN	Decreases Expression	[6]
Transforming growth factor beta-2 proprotein (TGFB2)	OTC0TXEP	TGFB2_HUMAN	Decreases Expression	[6]
Phosphoserine phosphatase (PSPH)	OTV1PVAX	SERB_HUMAN	Decreases Expression	[6]
Protein jagged-1 (JAG1)	OT3LGT6K	JAG1_HUMAN	Decreases Expression	[6]
4-aminobutyrate aminotransferase, mitochondrial (ABAT)	OTXAGR7J	GABT_HUMAN	Decreases Expression	[6]
Low-density lipoprotein receptor-related protein 2 (LRP2)	OTZ6W681	LRP2_HUMAN	Decreases Expression	[6]
Large neutral amino acids transporter small subunit 1 (SLC7A5)	OT2WPVXD	LAT1_HUMAN	Increases Expression	[6]
Cyclic AMP-responsive element-binding protein 5 (CREB5)	OTJDUJPI	CREB5_HUMAN	Increases Expression	[6]
Transcription factor SOX-4 (SOX4)	OTSS40SS	SOX4_HUMAN	Decreases Expression	[6]
Amino acid transporter heavy chain SLC3A1 (SLC3A1)	OT56V01A	SLC31_HUMAN	Decreases Expression	[6]
Cadherin-18 (CDH18)	OTC06P9H	CAD18_HUMAN	Decreases Expression	[6]
Calcyphosin (CAPS)	OTC9GZ2M	CAYP1_HUMAN	Increases Expression	[6]
Transcription factor Dp-2 (TFDP2)	OTKQFX5H	TFDP2_HUMAN	Decreases Expression	[6]
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (PDE3A)	OTKUW1WT	PDE3A_HUMAN	Decreases Expression	[6]
Next to BRCA1 gene 1 protein (NBR1)	OTVRL7J9	NBR1_HUMAN	Decreases Expression	[6]
Pericentriolar material 1 protein (PCM1)	OTFM133C	PCM1_HUMAN	Decreases Expression	[6]
Neutral amino acid transporter B(0) (SLC1A5)	OTE2H26Q	AAAT_HUMAN	Increases Expression	[6]
Adiponectin (ADIPOQ)	OTNX23LE	ADIPO_HUMAN	Decreases Expression	[6]
Dual specificity protein phosphatase 5 (DUSP5)	OTH96RA7	DUS5_HUMAN	Increases Expression	[6]
Protein Dok-7 (DOK7)	OTR2V7HO	DOK7_HUMAN	Increases Expression	[6]
Protein GREB1 (GREB1)	OTU6ZA26	GREB1_HUMAN	Increases Expression	[6]
Piercer of microtubule wall 1 protein (PIERCE1)	OTONT0CN	PIRC1_HUMAN	Decreases Expression	[6]
Retrotransposon Gag-like protein 5 (RTL5)	OT9ZJR3N	RTL5_HUMAN	Decreases Expression	[6]
Protein phosphatase 1J (PPM1J)	OTM6GDJJ	PPM1J_HUMAN	Increases Expression	[6]
Immediate early response gene 5-like protein (IER5L)	OT6IG629	IER5L_HUMAN	Increases Expression	[6]
Disabled homolog 2-interacting protein (DAB2IP)	OTF456VC	DAB2P_HUMAN	Affects Expression	[6]
Muscleblind-like protein 2 (MBNL2)	OTF7CF1F	MBNL2_HUMAN	Decreases Expression	[6]
Anoctamin-1 (ANO1)	OTSREUNI	ANO1_HUMAN	Increases Expression	[6]
Proline-rich membrane anchor 1 (PRIMA1)	OT9ITT3P	PRIMA_HUMAN	Decreases Expression	[6]
Prolyl 3-hydroxylase 2 (P3H2)	OTY84H6U	P3H2_HUMAN	Decreases Expression	[6]
E3 ubiquitin-protein ligase TRIM22 (TRIM22)	OTJBLG5R	TRI22_HUMAN	Decreases Expression	[6]
Solute carrier family 25 member 45 (SLC25A45)	OTP7EAUM	S2545_HUMAN	Decreases Expression	[6]
PACRG-like protein (PACRGL)	OT5DEP0X	PACRL_HUMAN	Increases Expression	[6]
N-acetylaspartate synthetase (NAT8L)	OTA96AVN	NAT8L_HUMAN	Decreases Expression	[6]
Retinoic acid-induced protein 3 (GPRC5A)	OTPOCWR7	RAI3_HUMAN	Decreases Expression	[6]
Two pore channel protein 2 (TPCN2)	OTLAF3ED	TPC2_HUMAN	Decreases Expression	[6]
LIM domain only protein 3 (LMO3)	OTR7AJHN	LMO3_HUMAN	Decreases Expression	[6]
DEP domain-containing mTOR-interacting protein (DEPTOR)	OTCBP1BT	DPTOR_HUMAN	Increases Expression	[6]
Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8L1)	OT83O8WI	ES8L1_HUMAN	Decreases Expression	[6]
Complexin-3 (CPLX3)	OT0YTMN2	CPLX3_HUMAN	Decreases Expression	[6]
Histone acetyltransferase KAT2B (KAT2B)	OTWQITWK	KAT2B_HUMAN	Decreases Expression	[6]
Protein kinase C-binding protein NELL1 (NELL1)	OTF3TX3N	NELL1_HUMAN	Decreases Expression	[6]
LIM/homeobox protein Lhx4 (LHX4)	OTVX3J6S	LHX4_HUMAN	Increases Expression	[6]
E3 ubiquitin-protein ligase MIB2 (MIB2)	OTJCC3HS	MIB2_HUMAN	Decreases Expression	[6]
Dedicator of cytokinesis protein 10 (DOCK10)	OTI3MBLV	DOC10_HUMAN	Decreases Expression	[6]
Galactose mutarotase (GALM)	OT7UPL4D	GALM_HUMAN	Decreases Expression	[6]
Endoplasmic reticulum resident protein 27 (ERP27)	OTVMGE2H	ERP27_HUMAN	Decreases Expression	[6]
Hedgehog-interacting protein (HHIP)	OT77RQYS	HHIP_HUMAN	Decreases Expression	[6]
TSC22 domain family protein 3 (TSC22D3)	OT03UM03	T22D3_HUMAN	Decreases Expression	[6]
Neurturin (NRTN)	OT4PAKUY	NRTN_HUMAN	Increases Expression	[6]
Ras-like protein family member 11B (RASL11B)	OTHEVZS6	RSLBB_HUMAN	Decreases Expression	[6]
Mitochondrial ribosome-associated GTPase 1 (MTG1)	OTC9U1LI	MTG1_HUMAN	Decreases Expression	[6]
Melanophilin (MLPH)	OT7ADCXL	MELPH_HUMAN	Increases Expression	[6]
RNA-binding protein 24 (RBM24)	OTQI1AR1	RBM24_HUMAN	Increases Expression	[6]
Keratin-associated protein 2-1 (KRTAP2-1)	OTV1SGF2	KRA21_HUMAN	Decreases Expression	[6]
Keratin, type I cytoskeletal 23 (KRT23)	OTQW6UAG	K1C23_HUMAN	Decreases Expression	[6]
Cysteine-rich secretory protein LCCL domain-containing 1 (CRISPLD1)	OT38HXJP	CRLD1_HUMAN	Increases Expression	[6]
Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2)	OTAQD3YV	ARNT2_HUMAN	Decreases Expression	[6]
Plexin-A4 (PLXNA4)	OT5XKB3Q	PLXA4_HUMAN	Decreases Expression	[6]
Palmdelphin (PALMD)	OTRLOZ4Y	PALMD_HUMAN	Decreases Expression	[6]
Transcription and mRNA export factor ENY2 (ENY2)	OTTNU8RK	ENY2_HUMAN	Decreases Expression	[6]
Signal peptide, CUB and EGF-like domain-containing protein 2 (SCUBE2)	OT661S7D	SCUB2_HUMAN	Decreases Expression	[6]
Cytochrome P450 26B1 (CYP26B1)	OT92XA92	CP26B_HUMAN	Decreases Expression	[6]
Olfactomedin-like protein 3 (OLFML3)	OTDN45FN	OLFL3_HUMAN	Increases Expression	[6]
Cytokine-inducible SH2-containing protein (CISH)	OT8T5NYL	CISH_HUMAN	Increases Expression	[6]
ATPase family AAA domain-containing protein 3A (ATAD3A)	OTWF6HBP	ATD3A_HUMAN	Decreases Expression	[6]
Kv channel-interacting protein 1 (KCNIP1)	OTGLGK1R	KCIP1_HUMAN	Decreases Expression	[6]
Denticleless protein homolog (DTL)	OTC29RYE	DTL_HUMAN	Increases Expression	[6]
Peroxisomal sarcosine oxidase (PIPOX)	OTWTCOTN	SOX_HUMAN	Increases Expression	[6]
A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAMTS9)	OTV3Q0DS	ATS9_HUMAN	Increases Expression	[6]
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A)	OTHCDQ22	PRGC1_HUMAN	Decreases Expression	[6]
Dickkopf-related protein 3 (DKK3)	OTDU94EY	DKK3_HUMAN	Decreases Expression	[6]
Protein NDRG2 (NDRG2)	OT5L6KD7	NDRG2_HUMAN	Decreases Expression	[6]
Rho family-interacting cell polarization regulator 2 (RIPOR2)	OTXB6LIR	RIPR2_HUMAN	Decreases Expression	[6]
Transcription factor HES-2 (HES2)	OTMWY2KV	HES2_HUMAN	Increases Expression	[6]
Tolloid-like protein 2 (TLL2)	OTHZ4TBL	TLL2_HUMAN	Increases Expression	[6]
Metallothionein-2 (MT2A)	OTHOACHD	MT2_HUMAN	Increases Expression	[16]
Aryl hydrocarbon receptor (AHR)	OTFE4EYE	AHR_HUMAN	Affects Activity	[16]
S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1)	OTX8L3M5	SAHH2_HUMAN	Affects Expression	[7]
Putative hydrolase DDAH2 (DDAH2)	OT8Q40G2	DDAH2_HUMAN	Affects Expression	[7]
Integrin beta-3 (ITGB3)	OTWCK1K6	ITB3_HUMAN	Affects Expression	[7]
Small integral membrane protein 6 (SMIM6)	OTRGL3O1	SMIM6_HUMAN	Affects Expression	[7]
Heat shock 70 kDa protein 1A (HSPA1A)	OTKGIE76	HS71A_HUMAN	Affects Expression	[7]
Integrin beta-6 (ITGB6)	OTI3DJ7U	ITB6_HUMAN	Affects Expression	[7]
Deoxyribonuclease-1 (DNASE1)	OTM4KWB3	DNAS1_HUMAN	Affects Expression	[7]
G0/G1 switch protein 2 (G0S2)	OT8FL49L	G0S2_HUMAN	Affects Expression	[7]
G1/S-specific cyclin-D2 (CCND2)	OTDULQF9	CCND2_HUMAN	Affects Expression	[7]
Homeobox protein MOX-1 (MEOX1)	OTJEMT2D	MEOX1_HUMAN	Affects Expression	[7]
Diacylglycerol kinase epsilon (DGKE)	OTWS86AS	DGKE_HUMAN	Affects Expression	[7]
Cadherin-6 (CDH6)	OT81Y80S	CADH6_HUMAN	Affects Expression	[7]
Phospholipid-transporting ATPase ID (ATP8B2)	OTH5WJ09	AT8B2_HUMAN	Affects Expression	[7]
Transgelin (TAGLN)	OTAEZ0KP	TAGL_HUMAN	Affects Expression	[7]
Programmed cell death protein 4 (PDCD4)	OTZ6NXUX	PDCD4_HUMAN	Affects Expression	[7]
Sclerostin domain-containing protein 1 (SOSTDC1)	OTAKDNSM	SOSD1_HUMAN	Affects Expression	[7]
Transmembrane protein 64 (TMEM64)	OTO9IDFD	TMM64_HUMAN	Affects Expression	[7]
Echinoderm microtubule-associated protein-like 6 (EML6)	OTE1MUQS	EMAL6_HUMAN	Affects Expression	[7]
PX domain-containing protein kinase-like protein (PXK)	OTSP1WLK	PXK_HUMAN	Affects Expression	[7]
Protein limb expression 1 homolog (LIX1)	OT1CPNCC	LIX1_HUMAN	Affects Expression	[7]
Uncharacterized protein FAM241A (FAM241A)	OTC12ETA	F241A_HUMAN	Affects Expression	[7]
RalBP1-associated Eps domain-containing protein 2 (REPS2)	OTSE3TRP	REPS2_HUMAN	Affects Expression	[7]
Syntaxin-binding protein 6 (STXBP6)	OTUEKTIP	STXB6_HUMAN	Affects Expression	[7]
POC1 centriolar protein homolog B (POC1B)	OTDIMIRZ	POC1B_HUMAN	Affects Expression	[7]
Solute carrier family 2, facilitated glucose transporter member 12 (SLC2A12)	OT0EDNV9	GTR12_HUMAN	Affects Expression	[7]
Pleckstrin homology-like domain family A member 1 (PHLDA1)	OTFTWMIQ	PHLA1_HUMAN	Affects Expression	[7]
Peroxidasin homolog (PXDN)	OTFGGM9R	PXDN_HUMAN	Affects Expression	[7]
Secreted frizzled-related protein 3 (FRZB)	OTTO3DPY	SFRP3_HUMAN	Affects Expression	[7]
DNA endonuclease RBBP8 (RBBP8)	OTRHJ3GI	CTIP_HUMAN	Affects Expression	[7]
Transmembrane protease serine 4 (TMPRSS4)	OTCCGY2K	TMPS4_HUMAN	Affects Expression	[7]
Cdc42 effector protein 3 (CDC42EP3)	OTUZ3U9Z	BORG2_HUMAN	Affects Expression	[7]
Teneurin-1 (TENM1)	OTSKSU4V	TEN1_HUMAN	Affects Expression	[7]
RNA polymerase II elongation factor ELL2 (ELL2)	OTZJRTFM	ELL2_HUMAN	Affects Expression	[8]
Mothers against decapentaplegic homolog 6 (SMAD6)	OTUZZWUD	SMAD6_HUMAN	Affects Expression	[8]
Nuclear receptor subfamily 1 group I member 2 (NR1I2)	OTC5U0N5	NR1I2_HUMAN	Increases Activity	[18]
RAS guanyl-releasing protein 1 (RASGRP1)	OTX9WN2E	GRP1_HUMAN	Affects Expression	[8]
Bile salt export pump (ABCB11)	OTRU7THO	ABCBB_HUMAN	Decreases Expression	[19]
Cytochrome c oxidase subunit 3 (COX3)	OTNNGBYJ	COX3_HUMAN	Increases Expression	[20]
Prothrombin (F2)	OTNFSM49	THRB_HUMAN	Increases Expression	[21]
Plasminogen (PLG)	OTWWIPPY	PLMN_HUMAN	Increases Expression	[22]
Renin (REN)	OT52GZR2	RENI_HUMAN	Increases Activity	[23]
ATP synthase subunit a (ATP6)	OTPHOGLX	ATP6_HUMAN	Increases Expression	[20]
Antithrombin-III (SERPINC1)	OTDFATG0	ANT3_HUMAN	Decreases Activity	[22]
Angiotensinogen (AGT)	OTBZLYR3	ANGT_HUMAN	Increases Expression	[23]
Low-density lipoprotein receptor (LDLR)	OTH559LU	LDLR_HUMAN	Increases Expression	[24]
Follitropin subunit beta (FSHB)	OTGLS283	FSHB_HUMAN	Decreases Expression	[25]
Lutropin subunit beta (LHB)	OT5GBOVJ	LSHB_HUMAN	Decreases Activity	[26]
Somatotropin (GH1)	OT92RTRD	SOMA_HUMAN	Increases Expression	[25]
Insulin-like growth factor II (IGF2)	OTJ4O6MW	IGF2_HUMAN	Increases Expression	[27]
C-reactive protein (CRP)	OT0RFT8F	CRP_HUMAN	Increases Expression	[28]
Estrogen receptor (ESR1)	OTKLU61J	ESR1_HUMAN	Increases Expression	[29]
Trefoil factor 1 (TFF1)	OTCYQH4F	TFF1_HUMAN	Increases Expression	[30]
Histidine-rich glycoprotein (HRG)	OTPLUFOG	HRG_HUMAN	Decreases Expression	[31]
Sex hormone-binding globulin (SHBG)	OTPWU5IW	SHBG_HUMAN	Increases Expression	[32]
Cellular tumor antigen p53 (TP53)	OTIE1VH3	P53_HUMAN	Affects Activity	[33]
Insulin-like growth factor I (IGF1)	OTIIZR61	IGF1_HUMAN	Decreases Expression	[25]
Endothelin-1 (EDN1)	OTZCACEG	EDN1_HUMAN	Affects Expression	[8]
Transcription factor Jun (JUN)	OTCYBO6X	JUN_HUMAN	Affects Expression	[34]
Thrombomodulin (THBD)	OT8VHLKY	TRBM_HUMAN	Decreases Expression	[21]
Vitamin K-dependent protein S (PROS1)	OTXQWNOI	PROS_HUMAN	Decreases Expression	[22]
Transcription factor Sp1 (SP1)	OTISPT4X	SP1_HUMAN	Increases Activity	[35]
Asparagine synthetase (ASNS)	OT8R922G	ASNS_HUMAN	Affects Expression	[8]
Coagulation factor VII (F7)	OTGNJ97M	FA7_HUMAN	Increases Expression	[21]
Osteopontin (SPP1)	OTJGC23Y	OSTP_HUMAN	Affects Expression	[8]
Chromogranin-A (CHGA)	OTXYX5JH	CMGA_HUMAN	Affects Expression	[8]
Serine/threonine-protein kinase pim-1 (PIM1)	OTWEKXTU	PIM1_HUMAN	Affects Expression	[8]
Keratin, type II cytoskeletal 5 (KRT5)	OTVGI9HT	K2C5_HUMAN	Affects Expression	[8]
Beta-1,4-galactosyltransferase 1 (B4GALT1)	OTBCXEK7	B4GT1_HUMAN	Increases Expression	[36]
Fos-related antigen 1 (FOSL1)	OT9YTYMB	FOSL1_HUMAN	Affects Expression	[8]
Gap junction alpha-1 protein (GJA1)	OTT94MKL	CXA1_HUMAN	Increases Expression	[37]
Insulin-like growth factor-binding protein 2 (IGFBP2)	OTG1P60E	IBP2_HUMAN	Decreases Expression	[27]
Cyclic AMP-dependent transcription factor ATF-3 (ATF3)	OTC1UOHP	ATF3_HUMAN	Increases Expression	[38]
Myelin and lymphocyte protein (MAL)	OTBM30SW	MAL_HUMAN	Affects Expression	[8]
Insulin-like growth factor-binding protein 4 (IGFBP4)	OT2HZRBD	IBP4_HUMAN	Increases Expression	[27]
Mitogen-activated protein kinase 1 (MAPK1)	OTH85PI5	MK01_HUMAN	Increases Activity	[39]
Insulin-like growth factor-binding protein complex acid labile subunit (IGFALS)	OTTWCZYM	ALS_HUMAN	Decreases Expression	[25]
ETS translocation variant 5 (ETV5)	OTE2OBM4	ETV5_HUMAN	Affects Expression	[8]
Radiation-inducible immediate-early gene IEX-1 (IER3)	OTZJI5FZ	IEX1_HUMAN	Affects Expression	[8]
Solute carrier organic anion transporter family member 1A2 (SLCO1A2)	OTO70C5O	SO1A2_HUMAN	Decreases Expression	[19]
Stromal cell-derived factor 1 (CXCL12)	OT2QX5LL	SDF1_HUMAN	Increases Expression	[40]
NADP-dependent malic enzyme (ME1)	OTSVEUQE	MAOX_HUMAN	Affects Expression	[8]
Glutamate--cysteine ligase catalytic subunit (GCLC)	OTESDI4D	GSH1_HUMAN	Affects Expression	[8]
Cysteine--tRNA ligase, cytoplasmic (CARS1)	OTOUZF6O	SYCC_HUMAN	Affects Expression	[8]
Serine--tRNA ligase, cytoplasmic (SARS1)	OTFKXQ1O	SYSC_HUMAN	Affects Expression	[8]
CCAAT/enhancer-binding protein delta (CEBPD)	OTNBIPMY	CEBPD_HUMAN	Affects Expression	[8]
Inhibin beta E chain (INHBE)	OTOI2NYG	INHBE_HUMAN	Affects Expression	[8]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)	OTOWDUNT	PTEN_HUMAN	Affects Expression	[8]
Transformer-2 protein homolog beta (TRA2B)	OTZYQW52	TRA2B_HUMAN	Increases Expression	[41]
Small ribosomal subunit protein RACK1 (RACK1)	OTZBCQ1U	RACK1_HUMAN	Increases Expression	[42]
E3 ubiquitin-protein ligase Mdm2 (MDM2)	OTOVXARF	MDM2_HUMAN	Increases Expression	[43]
Schlafen family member 5 (SLFN5)	OTT1AESL	SLFN5_HUMAN	Affects Expression	[8]
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)	OTXEE550	APR_HUMAN	Affects Expression	[8]
Four and a half LIM domains protein 2 (FHL2)	OT0OAYWT	FHL2_HUMAN	Affects Expression	[8]
Hepatic sodium/bile acid cotransporter (SLC10A1)	OTUJVMCL	NTCP_HUMAN	Decreases Expression	[19]
Nuclear receptor subfamily 1 group I member 3 (NR1I3)	OTS3SGH7	NR1I3_HUMAN	Increases Activity	[44]
Advanced glycosylation end product-specific receptor (AGER)	OTPY0IH7	RAGE_HUMAN	Increases Expression	[35]
Erythroferrone (ERFE)	OTSES1HA	ERFE_HUMAN	Affects Expression	[8]
FYVE, RhoGEF and PH domain-containing protein 3 (FGD3)	OTIH6283	FGD3_HUMAN	Affects Expression	[8]
Na(+)/H(+) exchange regulatory cofactor NHE-RF3 (PDZK1)	OTGFK4MH	NHRF3_HUMAN	Increases Expression	[36]
Early estrogen-induced gene 1 protein (EEIG1)	OT2BMEAE	EEIG1_HUMAN	Increases Expression	[36]
Very-long-chain (HACD2)	OTAZO9F6	HACD2_HUMAN	Affects Expression	[8]
Retrotransposon-derived protein PEG10 (PEG10)	OTWD2278	PEG10_HUMAN	Affects Expression	[8]
Ly6/PLAUR domain-containing protein 1 (LYPD1)	OT0HSGML	LYPD1_HUMAN	Affects Expression	[8]
Scavenger receptor class B member 1 (SCARB1)	OTAE1UA1	SCRB1_HUMAN	Affects Splicing	[41]
Stonin-2 (STON2)	OT01JHHE	STON2_HUMAN	Affects Expression	[8]
Protein NDRG1 (NDRG1)	OTVO66BO	NDRG1_HUMAN	Affects Expression	[8]
Estrogen receptor beta (ESR2)	OTXNR2WQ	ESR2_HUMAN	Increases Activity	[45]
ATP-binding cassette sub-family C member 2 (ABCC2)	OTJSIGV5	MRP2_HUMAN	Decreases Expression	[19]
Tumor protein p53-inducible nuclear protein 1 (TP53INP1)	OT2363Z9	T53I1_HUMAN	Affects Expression	[8]
Mediator of RNA polymerase II transcription subunit 8 (MED8)	OTSIZ1I7	MED8_HUMAN	Affects Expression	[8]
Bile acid receptor (NR1H4)	OTWZLPTB	NR1H4_HUMAN	Decreases Expression	[19]
Tribbles homolog 3 (TRIB3)	OTG5OS7X	TRIB3_HUMAN	Affects Expression	[8]
G-protein coupled estrogen receptor 1 (GPER1)	OTUK0TDC	GPER1_HUMAN	Increases Expression	[29]
Angiotensin-converting enzyme 2 (ACE2)	OTTRZGU7	ACE2_HUMAN	Decreases Expression	[46]
Protein associated with UVRAG as autophagy enhancer (RUBCNL)	OTMQIDOI	PACER_HUMAN	Affects Expression	[8]
Tetratricopeptide repeat protein 12 (TTC12)	OTDB24YV	TTC12_HUMAN	Affects Expression	[8]
Solute carrier family 40 member 1 (SLC40A1)	OT8RV2VY	S40A1_HUMAN	Affects Expression	[8]
Matrix-remodeling-associated protein 5 (MXRA5)	OTXZBWCU	MXRA5_HUMAN	Affects Expression	[8]
Signal-induced proliferation-associated 1-like protein 2 (SIPA1L2)	OT8NJE5D	SI1L2_HUMAN	Affects Expression	[8]
Kelch-like protein 14 (KLHL14)	OTYOS55H	KLH14_HUMAN	Affects Expression	[8]
Transcription factor MafF (MAFF)	OT9B7MX0	MAFF_HUMAN	Affects Expression	[8]
Cystine/glutamate transporter (SLC7A11)	OTKJ6PXW	XCT_HUMAN	Affects Expression	[8]
Proton-coupled zinc antiporter SLC30A1 (SLC30A1)	OTY8J0S4	ZNT1_HUMAN	Affects Expression	[8]
SET-binding protein (SETBP1)	OTKGCOSR	SETBP_HUMAN	Affects Expression	[8]
Sulfotransferase 2A1 (SULT2A1)	OT0ISKQ4	ST2A1_HUMAN	Increases Metabolism	[47]
Sulfotransferase 1A1 (SULT1A1)	OT0K7JIE	ST1A1_HUMAN	Increases Metabolism	[47]
ATP-binding cassette sub-family C member 3 (ABCC3)	OTC3IJV4	MRP3_HUMAN	Increases Uptake	[48]
Cytochrome P450 (CYP2B)	OTDDG81I	Q14097_HUMAN	Increases ADR	[49]
Sulfotransferase 1B1 (SULT1B1)	OTH0RQYA	ST1B1_HUMAN	Increases Metabolism	[47]
Sulfotransferase 1A3 (SULT1A4)	OTHJ8WWV	ST1A3_HUMAN	Increases Sulfation	[50]
Cytochrome P450 1A2 (CYP1A2)	OTLLBX48	CP1A2_HUMAN	Increases Hydroxylation	[13]
Fibroblast growth factor 4 (FGF4)	OTNVV3ZG	FGF4_HUMAN	Increases ADR	[49]
Cytochrome P450 2B6 (CYP2B6)	OTOYO4S7	CP2B6_HUMAN	Affects Metabolism	[51]
Cytochrome P450 3A5 (CYP3A5)	OTSXFBXB	CP3A5_HUMAN	Increases Hydroxylation	[13]
------------------------------------------------------------------------------------


⏷ Show the Full List of 280 DOT(s)

Indication(s) of Brincidofovir

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[4]

References

1	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2	Ethinyl estradiol FDA Label
3	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7071).
4	A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol. 2020 May 1;10.1111/bph.15094.
5	Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos. 2007 Dec;35(12):2270-80.
6	The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
7	Dose- and time-dependent transcriptional response of Ishikawa cells exposed to genistein. Toxicol Sci. 2016 May;151(1):71-87.
8	The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
9	17alpha-Ethinylestradiol hinders nucleotide excision repair in zebrafish liver cells. Aquat Toxicol. 2009 Dec 13;95(4):273-8.
10	P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93.
11	Rifampicin, a keystone inducer of drug metabolism: from Herbert Remmer's pioneering ideas to modern concepts. Drug Metab Rev. 2004 Oct;36(3-4):497-509.
12	Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004 Nov;32(11):1201-8.
13	The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol. Drug Metab Dispos. 2004 Nov;32(11):1209-12.
14	Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol. 2005 Jan;45(1):68-78.
15	The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects. Br J Clin Pharmacol. 2003 Aug;56(2):232-7.
16	The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol. Arch Toxicol. 2013 Apr;87(4):633-43.
17	Development and validation of a fluorescence HPLC-based screening assay for inhibition of human estrogen sulfotransferase. Anal Biochem. 2006 Oct 1;357(1):85-92.
18	Development of a common carp (Cyprinus carpio) pregnane X receptor (cPXR) transactivation reporter assay and its activation by azole fungicides and pharmaceutical chemicals. Toxicol In Vitro. 2017 Jun;41:114-122. doi: 10.1016/j.tiv.2017.02.023. Epub 2017 Mar 1.
19	UDCA and CDCA alleviate 17-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats. Toxicol Appl Pharmacol. 2016 Nov 15;311:12-25. doi: 10.1016/j.taap.2016.10.011. Epub 2016 Oct 12.
20	Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcinogenesis and after estrogen treatment of HepG2 cells. Carcinogenesis. 1998 Dec;19(12):2187-93. doi: 10.1093/carcin/19.12.2187.
21	Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb Haemost. 1996 Nov;76(5):729-34.
22	Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study. J Clin Endocrinol Metab. 2007 Jun;92(6):2074-9. doi: 10.1210/jc.2007-0026. Epub 2007 Mar 20.
23	Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration. J Clin Endocrinol Metab. 2000 Nov;85(11):4331-7. doi: 10.1210/jcem.85.11.6932.
24	Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue. Contraception. 2007 Oct;76(4):297-305. doi: 10.1016/j.contraception.2007.06.011. Epub 2007 Sep 14.
25	Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. J Clin Endocrinol Metab. 2000 May;85(5):1918-22. doi: 10.1210/jcem.85.5.6527.
26	Estrogenic Compounds or Adiponectin Inhibit Cyclic AMP Response to Human Luteinizing Hormone in Mouse Leydig Tumor Cells. Biology (Basel). 2019 Jun 11;8(2):45. doi: 10.3390/biology8020045.
27	Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol. 2005 Apr;152(4):597-604. doi: 10.1530/eje.1.01880.
28	Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men. Thromb Haemost. 2000 Aug;84(2):359-60.
29	Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression. Ecotoxicol Environ Saf. 2018 Sep 30;160:1-9. doi: 10.1016/j.ecoenv.2018.05.025. Epub 2018 May 21.
30	Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals. Toxicol In Vitro. 2022 Jun;81:105348. doi: 10.1016/j.tiv.2022.105348. Epub 2022 Mar 18.
31	Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way. Thromb Haemost. 1995 Mar;73(3):484-7.
32	Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations. Calcif Tissue Int. 2002 Jan;70(1):11-21. doi: 10.1007/s002230020035. Epub 2001 Dec 21.
33	Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation. Arch Toxicol. 2022 Jul;96(7):1975-1987. doi: 10.1007/s00204-022-03291-5. Epub 2022 Apr 18.
34	Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity. Toxicology. 2014 Jun 5;320:46-55. doi: 10.1016/j.tox.2014.03.007. Epub 2014 Mar 28.
35	Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells. Biochim Biophys Acta. 2005 Sep 30;1745(3):300-9. doi: 10.1016/j.bbamcr.2005.03.012. Epub 2005 Apr 12.
36	Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol. 2004 Feb;18(2):402-11. doi: 10.1210/me.2003-0202. Epub 2003 Nov 6.
37	Increased expression of estrogen receptor beta in human uterine smooth muscle at term. Eur J Endocrinol. 2000 Jan;142(1):92-9. doi: 10.1530/eje.0.1420092.
38	Estradiol upregulates activating transcription factor 3, a candidate gene in the etiology of hypospadias. Pediatr Dev Pathol. 2007 Nov-Dec;10(6):446-54. doi: 10.2350/06-04-0079.1.
39	Synthetic estrogen-mediated activation of ERK 2 intracellular signaling molecule. Gynecol Endocrinol. 2003 Oct;17(5):423-8. doi: 10.1080/09513590312331290338.
40	Novel full logistic model for estimation of the estrogenic activity of chemical mixtures. Toxicology. 2016 Jun 1;359-360:58-70. doi: 10.1016/j.tox.2016.06.017. Epub 2016 Jun 29.
41	Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors. Endocrinology. 2007 Nov;148(11):5295-304. doi: 10.1210/en.2007-0376. Epub 2007 Aug 2.
42	Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation. Toxicology. 2022 Oct;480:153321. doi: 10.1016/j.tox.2022.153321. Epub 2022 Sep 13.
43	Detection of MDM2 alterations in cultured human hepatocytes treated with 17beta-estradiol or 17alpha-ethinylestradiol. Anticancer Res. 2002 May-Jun;22(3):1545-51.
44	Agonistic effects of diverse xenobiotics on the constitutive androstane receptor as detected in a recombinant yeast-cell assay. Toxicol In Vitro. 2018 Feb;46:335-349. doi: 10.1016/j.tiv.2017.09.014. Epub 2017 Sep 18.
45	Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ Sci Technol. 2002 Oct 15;36(20):4410-5. doi: 10.1021/es010323a.
46	Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. Arch Toxicol. 2020 Dec;94(12):4037-4041. doi: 10.1007/s00204-020-02869-1. Epub 2020 Aug 17.
47	Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem Biophys Res Commun. 2000 Jan 7;267(1):80-4. doi: 10.1006/bbrc.1999.1935.
48	Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. J Pharmacol Exp Ther. 2004 Apr;309(1):156-64. doi: 10.1124/jpet.103.062091. Epub 2004 Jan 13.
49	ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
50	Sulfotransferase 1E1 is a low km isoform mediating the 3-O-sulfation of ethinyl estradiol. Drug Metab Dispos. 2004 Nov;32(11):1299-303. doi: 10.1124/dmd.32.11..
51	Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6. Chem Res Toxicol. 2006 Feb;19(2):279-87. doi: 10.1021/tx050256o.